Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08
Published April 22, 2020 · Recall initiated: March 18, 2020
Summary
FDA records drug Class II recall D-1233-2020, published April 22, 2020 and initiated March 18, 2020. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 8040 units; Lot: Lot #: 24719001A1, Exp. Date 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVETIRACETAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVETIRACETAM
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 24719001A1, Exp. Date 03/2021
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDAGabapentin Capsules, USP 100mg 1,000-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc.April 22, 2020
- FDASimvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJApril 22, 2020
- FDALevetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg per 100 mL (15 mg/mL), For Intravenous InfusionMay 9, 2018
- FDALevetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only,May 9, 2018
- FDALevetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, ManufacturedDecember 6, 2017
Questions about this recall
Was Levetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, NDC 65862-247-08 recalled?
Yes. FDA published recall D-1233-2020 on April 22, 2020. Reported hazard: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVETIRACETAM.